Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia.

Mimoz O, Rolland D, Adoun M, Marchand S, Breilh D, Brumpt I, Debaene B, Couet W.

Intensive Care Med. 2006 May;32(5):775-9. Epub 2006 Mar 21.

PMID:
16550370
2.

Simultaneous determination of metronidazole and spiramycin I in human plasma, saliva and gingival crevicular fluid by LC-MS/MS.

Sagan C, Salvador A, Dubreuil D, Poulet PP, Duffaut D, Brumpt I.

J Pharm Biomed Anal. 2005 Jun 15;38(2):298-306. Epub 2005 Feb 17.

PMID:
15925222
3.
4.

[Efficacy of levofloxacin in the treatment of acute exacerbation of chronic bronchitis in patients with risk factors].

Zuck P, Veyssier P, Brumpt I.

Rev Pneumol Clin. 2004 Nov;60(5 Pt 1):269-77. French.

PMID:
15687910
5.

Randomized comparison of serum teicoplanin concentrations following daily or alternate daily dosing in healthy adults.

Rouveix B, Jehl F, Drugeon H, Brumpt I, Caulin E.

Antimicrob Agents Chemother. 2004 Jul;48(7):2394-9.

6.
7.

Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group.

Jaillon P, Morganroth J, Brumpt I, Talbot G.

J Antimicrob Chemother. 1996 May;37 Suppl A:161-7. Review.

PMID:
8737135
8.

Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studies.

Grassi GG, Brumpt I.

Drugs. 1995;49 Suppl 2:406-8. No abstract available.

PMID:
8549379
9.

Influence of rifampin on the pharmacokinetics of pefloxacin.

Humbert G, Brumpt I, Montay G, Le Liboux A, Frydman A, Borsa-Lebas F, Moore N.

Clin Pharmacol Ther. 1991 Dec;50(6):682-7.

PMID:
1752112
10.

[Uncomplicated lower urinary tract infection in women: new therapeutics].

Brumpt I.

Rev Prat. 1990 May 11;40(14):1271-4. French.

PMID:
2359933
11.

[Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose].

Guibert J, Kitzis MD, Brumpt I, Acar JF.

Pathol Biol (Paris). 1989 May;37(5):406-10. French.

PMID:
2506514
12.

[Febrile attacks, isolated and repeated caused by glafenine].

Brumpt I, Rouveix B, Salmon D, Vildé JL.

Therapie. 1982 Nov-Dec;37(6):697-8. French. No abstract available.

PMID:
6132464
13.

[Fatal complications of a single infusion of mithramycin].

Brumpt I, Baglin A, Alterescu R, Goguel A.

Nouv Presse Med. 1981 Dec 26;10(47):3853-4. French. No abstract available.

PMID:
6460221
14.

A seroepidemiological survey in the Gezira, Sudan, with special reference to arboviruses.

Omer AH, McLaren ML, Johnson BK, Chanas AC, Brumpt I, Gardner P, Draper CC.

J Trop Med Hyg. 1981 Apr;84(2):63-6.

PMID:
7218404
15.

[Non-typhoid salmonellosis].

Charmot G, Brumpt I.

Rev Prat. 1979 May 11;29(27):2217-8, 2221-7. French. No abstract available.

PMID:
545650
16.

[Transmission of plasmodium falciparum malaria by syringe in a patient with heroinism].

Bastin R, Charmot G, Brumpt I, Sansonetti P, Solal-Celigny P.

Nouv Presse Med. 1979 Feb 24;8(9):699-700. French. No abstract available.

PMID:
377220
17.

Biological activity of hepatitis B antigens in cell culture.

Brumpt I, Mann GF, Zuckerman AJ.

J Med Virol. 1978;3(2):157-64.

PMID:
569686

Supplemental Content

Loading ...
Support Center